Phytopharm Share News (PYM)

UPDATE 1-Phytopharm gives up after Parkinson's drug failure

LONDON, March 26 (Reuters) - British biotech Phytopharm gave up its search for a treatment for Parkinson's Disease using a drug derived from subtrop
[26 Mar '13]

STOCKS NEWS EUROPE-UK small caps climb 0.2 pct, outpace FTSE

The FTSE Small Caps index continues to outpace larger peers in midsession trade, gaining 0.2 percent, compared with falls of 0.1 percent and 0.3 perce
[18 Feb '13]

UPDATE 1-Phytopharm hit by failure of Parkinson's drug

* Parkinson's drug hope fails in major trial* Phytopharm's shares fall more than 80 pct (Adds details, analyst reaction, shares)LONDON, Feb 18 (Reut
[18 Feb '13]

STOCKS NEWS EUROPE-UK small caps climb 0.2 percent

The FTSE Small Cap index rises 0.2 percent in early deals, forging ahead of a flat FTSE 100 and FTSE 250.Greencore rebounds 5.9 percent after the food
[18 Feb '13]

BRIEF-Phytopharm's Cogane wins EU orphan drug status in ALS

LONDON, Sept 29 (Reuters) - Phytopharm PLC: * European Commission has granted Orphan Drug status to Cogane (PYM50028) for the treatment of
[29 Sep '11]

BRIEF-Phytopharm starts Phase II study of Cogane

LONDON, Nov 17 (Reuters) - Phytopharm PLC: * Announces commencement of Phase II study of Cogane in patients with Parkinson's disease
[17 Nov '10]

BRIEF-Phytopharm evaluating non-Cogane activities

LONDON, Aug 18 (Reuters) - Phytopharm PLC: * Priority remains on the progression of Cogane for the treatment of Parkinson's * B
[18 Aug '10]

BRIEF-Phytopharm names Tim Sharpington new CEO

LONDON, June 21 (Reuters) - Phytopharm PLC: * Appointment of chief executive officer * Tim Sharpington as chief executive officer and
[21 Jun '10]